Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy

Ovarian cancer is the leading cause of death from gynaecological malignancy. Despite improved detection and treatment options, relapse rates remain high. Combining immunotherapy with the current standard treatments may provide an improved prognosis, however, little is known about how standard chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Anthony, Govindaraj, Chindu, Xiang, Sue D., Halo, Julene, Quinn, Michael, Scalzo-Inguanti, Karen, Plebanski, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712704/
https://www.ncbi.nlm.nih.gov/pubmed/24213326
http://dx.doi.org/10.3390/cancers4020581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712704/
https://www.ncbi.nlm.nih.gov/pubmed/24213326
http://dx.doi.org/10.3390/cancers4020581

Ejemplares similares